BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 24121790)

  • 1. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.
    Levine DM; Ek WE; Zhang R; Liu X; Onstad L; Sather C; Lao-Sirieix P; Gammon MD; Corley DA; Shaheen NJ; Bird NC; Hardie LJ; Murray LJ; Reid BJ; Chow WH; Risch HA; Nyrén O; Ye W; Liu G; Romero Y; Bernstein L; Wu AH; Casson AG; Chanock SJ; Harrington P; Caldas I; Debiram-Beecham I; Caldas C; Hayward NK; Pharoah PD; Fitzgerald RC; Macgregor S; Whiteman DC; Vaughan TL
    Nat Genet; 2013 Dec; 45(12):1487-93. PubMed ID: 24121790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.
    Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common Variants Confer Susceptibility to Barrett's Esophagus: Insights from the First Genome-Wide Association Studies.
    Palles C; Findlay JM; Tomlinson I
    Adv Exp Med Biol; 2016; 908():265-90. PubMed ID: 27573776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma.
    Becker J; May A; Gerges C; Anders M; Veits L; Weise K; Czamara D; Lyros O; Manner H; Terheggen G; Venerito M; Noder T; Mayershofer R; Hofer JH; Karch HW; Ahlbrand CJ; Arras M; Hofer S; Mangold E; Heilmann-Heimbach S; Heinrichs SK; Hess T; Kiesslich R; Izbicki JR; Hölscher AH; Bollschweiler E; Malfertheiner P; Lang H; Moehler M; Lorenz D; Müller-Myhsok B; Ott K; Schmidt T; Whiteman DC; Vaughan TL; Nöthen MM; Hackelsberger A; Schumacher B; Pech O; Vashist Y; Vieth M; Weismüller J; Neuhaus H; Rösch T; Ell C; Gockel I; Schumacher J
    Cancer Med; 2015 Nov; 4(11):1700-4. PubMed ID: 26383589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus.
    Palles C; Chegwidden L; Li X; Findlay JM; Farnham G; Castro Giner F; Peppelenbosch MP; Kovac M; Adams CL; Prenen H; Briggs S; Harrison R; Sanders S; MacDonald D; Haigh C; Tucker A; Love S; Nanji M; deCaestecker J; Ferry D; Rathbone B; Hapeshi J; Barr H; Moayyedi P; Watson P; Zietek B; Maroo N; Gay L; Underwood T; Boulter L; McMurtry H; Monk D; Patel P; Ragunath K; Al Dulaimi D; Murray I; Koss K; Veitch A; Trudgill N; Nwokolo C; Rembacken B; Atherfold P; Green E; Ang Y; Kuipers EJ; Chow W; Paterson S; Kadri S; Beales I; Grimley C; Mullins P; Beckett C; Farrant M; Dixon A; Kelly S; Johnson M; Wajed S; Dhar A; Sawyer E; Roylance R; Onstad L; Gammon MD; Corley DA; Shaheen NJ; Bird NC; Hardie LJ; Reid BJ; Ye W; Liu G; Romero Y; Bernstein L; Wu AH; Casson AG; Fitzgerald R; Whiteman DC; Risch HA; Levine DM; Vaughan TL; Verhaar AP; van den Brande J; Toxopeus EL; Spaander MC; Wijnhoven BP; van der Laan LJ; Krishnadath K; Wijmenga C; Trynka G; McManus R; Reynolds JV; O'Sullivan J; MacMathuna P; McGarrigle SA; Kelleher D; Vermeire S; Cleynen I; Bisschops R; Tomlinson I; Jankowski J
    Gastroenterology; 2015 Feb; 148(2):367-78. PubMed ID: 25447851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma.
    Dong J; Maj C; Tsavachidis S; Ostrom QT; Gharahkhani P; Anderson LA; Wu AH; Ye W; Bernstein L; Borisov O; Schröder J; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; May A; Gerges C; Anders M; Venerito M; Schmidt T; Izbicki JR; Hölscher AH; Schumacher B; Vashist Y; Neuhaus H; Rösch T; Knapp M; Krawitz P; Böhmer A; Iyer PG; Reid BJ; Lagergren J; Shaheen NJ; Corley DA; Gockel I; Fitzgerald RC; ; Cook MB; Whiteman DC; Vaughan TL; Schumacher J; Thrift AP
    Gastroenterology; 2020 Dec; 159(6):2065-2076.e1. PubMed ID: 32918910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk.
    Dura P; van Veen EM; Salomon J; te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
    Int J Cancer; 2013 Oct; 133(7):1751-5. PubMed ID: 23504527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.
    Gharahkhani P; Fitzgerald RC; Vaughan TL; Palles C; Gockel I; Tomlinson I; Buas MF; May A; Gerges C; Anders M; Becker J; Kreuser N; Noder T; Venerito M; Veits L; Schmidt T; Manner H; Schmidt C; Hess T; Böhmer AC; Izbicki JR; Hölscher AH; Lang H; Lorenz D; Schumacher B; Hackelsberger A; Mayershofer R; Pech O; Vashist Y; Ott K; Vieth M; Weismüller J; Nöthen MM; ; ; ; Attwood S; Barr H; Chegwidden L; de Caestecker J; Harrison R; Love SB; MacDonald D; Moayyedi P; Prenen H; Watson RGP; Iyer PG; Anderson LA; Bernstein L; Chow WH; Hardie LJ; Lagergren J; Liu G; Risch HA; Wu AH; Ye W; Bird NC; Shaheen NJ; Gammon MD; Corley DA; Caldas C; Moebus S; Knapp M; Peters WHM; Neuhaus H; Rösch T; Ell C; MacGregor S; Pharoah P; Whiteman DC; Jankowski J; Schumacher J
    Lancet Oncol; 2016 Oct; 17(10):1363-1373. PubMed ID: 27527254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk.
    Lee E; Stram DO; Ek WE; Onstad LE; MacGregor S; Gharahkhani P; Ye W; Lagergren J; Shaheen NJ; Murray LJ; Hardie LJ; Gammon MD; Chow WH; Risch HA; Corley DA; Levine DM; Whiteman DC; Bernstein L; Bird NC; Vaughan TL; Wu AH
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1801-3. PubMed ID: 26364162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.
    Wu X; Ajani JA; Gu J; Chang DW; Tan W; Hildebrandt MA; Huang M; Wang KK; Hawk E
    Cancer Prev Res (Phila); 2013 Mar; 6(3):196-205. PubMed ID: 23466817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prioritization and functional analysis of GWAS risk loci for Barrett's esophagus and esophageal adenocarcinoma.
    Chen J; Ali MW; Yan L; Dighe SG; Dai JY; Vaughan TL; Casey G; Buas MF
    Hum Mol Genet; 2022 Feb; 31(3):410-422. PubMed ID: 34505128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
    Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
    Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
    Dong J; Levine DM; Buas MF; Zhang R; Onstad L; Fitzgerald RC; ; Corley DA; Shaheen NJ; Lagergren J; Hardie LJ; Reid BJ; Iyer PG; Risch HA; Caldas C; Caldas I; Pharoah PD; Liu G; Gammon MD; Chow WH; Bernstein L; Bird NC; Ye W; Wu AH; Anderson LA; MacGregor S; Whiteman DC; Vaughan TL; Thrift AP
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1598-1606.e4. PubMed ID: 29551738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of loci of functional relevance to Barrett's esophagus and esophageal adenocarcinoma: Cross-referencing of expression quantitative trait loci data from disease-relevant tissues with genetic association data.
    Schröder J; Schüller V; May A; Gerges C; Anders M; Becker J; Hess T; Kreuser N; Thieme R; Ludwig KU; Noder T; Venerito M; Veits L; Schmidt T; Fuchs C; Izbicki JR; Hölscher AH; Dakkak D; Jansen-Winkeln B; Moulla Y; Lyros O; Niebisch S; Mehdorn M; Lang H; Lorenz D; Schumacher B; Mayershofer R; Vashist Y; Ott K; Vieth M; Weismüller J; Mangold E; Nöthen MM; Moebus S; Knapp M; Neuhaus H; Rösch T; Ell C; Gockel I; Schumacher J; Böhmer AC
    PLoS One; 2019; 14(12):e0227072. PubMed ID: 31891614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
    Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
    Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium.
    Buas MF; Onstad L; Levine DM; Risch HA; Chow WH; Liu G; Fitzgerald RC; Bernstein L; Ye W; Bird NC; Romero Y; Casson AG; Corley DA; Shaheen NJ; Wu AH; Gammon MD; Reid BJ; Hardie LJ; Peters U; Whiteman DC; Vaughan TL
    PLoS One; 2015; 10(6):e0128617. PubMed ID: 26039359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
    Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
    Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
    Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.